Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$59.7 - $93.78 $722,370 - $1.13 Million
12,100 New
12,100 $798,000
Q1 2024

Apr 26, 2024

SELL
$72.54 - $95.56 $159,588 - $210,232
-2,200 Reduced 17.6%
10,300 $984,000
Q4 2023

Feb 14, 2024

BUY
$61.71 - $77.76 $98,736 - $124,416
1,600 Added 14.68%
12,500 $953,000
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $62,352 - $84,042
900 Added 9.0%
10,900 $755,000
Q2 2023

Aug 14, 2023

BUY
$81.41 - $94.33 $716,408 - $830,104
8,800 Added 733.33%
10,000 $943,000
Q1 2023

May 15, 2023

BUY
$74.26 - $84.51 $89,112 - $101,412
1,200 New
1,200 $99,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.6B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Caas Capital Management LP Portfolio

Follow Caas Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Caas Capital Management LP with notifications on news.